In GBM, cmvIL-10 has been proposed to promote PD-L1 expression which inhibits the actions of effector T-cells and NK cells, as well as contributes to the polarisation of TAMs into the M2 phenotype [1,114], though the mechanistic details in the tumour context require further validation. This evidence concerns the gene CD274 and glioblastoma.